EuropaBio

What EuropaBio does

EuropaBio, legally the European Association for Bioindustries (AISBL/IVZW), is Europe's largest biotechnology industry association, founded in 1996 and headquartered in Brussels, Belgium. The organization represents the full biotechnology ecosystem — from startups to global pharmaceutical and industrial firms, plus national biotechnology associations — encompassing over 5,000 biotech companies across Europe, of which 4,600 are SMEs. It does not develop or sell technology products; instead, it functions as a pan-European industry group that engages EU institutions, member states, and regulatory bodies (EMA, EFSA, ECHA) on legislative, regulatory, and economic frameworks for biotechnology applied across healthcare, industrial, and food sectors.

The association's "product surface" consists of advocacy outputs, policy positions, events, and member collaboration platforms. It organizes flagship events including EFIB (European Forum for Industrial Biotechnology), European Biotech Week, the Biomanufacturing Policy Summit, and the Patient BioForum. It operates dedicated councils and platforms — the Healthcare Biotechnology Council, Industrial Biotechnology Council, National Associations Council, SME Platform, and Biomanufacturing Platform — alongside EU-funded project participation (PRIMED under Horizon Europe, APROVALS regulatory sandbox). Enterprise members such as Novartis, Merck, MSD, Ipsen, Evonik, Sartorius, and Nestlé sit on the Board.

EuropaBio operates on a membership-funded, non-profit model under Belgian law. Revenue is generated through corporate and associate membership dues, national association membership fees, and event-related income (registrations, sponsorships for EFIB and European Biotech Week). It does not publicly disclose pricing or financial figures. It reaches members and policymakers through its website, email newsletters, position papers, consultation responses, press releases, webinars, and events. The organization is governed by a Board and Council structure led by Director General Dr. Claire Skentelbery, with the 2026 AGM (June 2026) having onboarded 19 new members and refreshed Board composition.

Name

EuropaBio

Legal name

European Association for Bioindustries (EUROPABIO)

Website

https://europabio.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

EuropaBio is Europe's largest biotechnology industry association, founded in 1996, representing 5,000+ biotech companies across healthcare, industrial, and food sectors through corporate members, SMEs, and national associations. It advocates for biotechnology policy and regulation at the EU level.

Ownership category

akta.pro rank

Product category

Biotechnology Industry Association Services

NAICS

Business Associations (81391)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Technical Committees, Working Groups & Expert Panels (BPADANAB)

Keywords

• Biotechnology industry association
• EU policy advocacy
• Biotech regulatory affairs
• Industry membership services
• Biomanufacturing advocacy

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: EuropaBio generates revenue through membership fees from corporate members, associate members, and national/regional biotechnology associations that represent thousands of biotech companies across Europe.
2. Event Revenue: The association organizes events including EFIB (European Forum for Industrial Biotechnology), European Biotech Week, and various conferences and webinars that generate revenue through registrations and sponsorship.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

EuropaBio is a non-profit industry association that represents Europe's biotechnology ecosystem through corporate, associate, and national-association memberships. It delivers policy advocacy, regulatory representation, and stakeholder engagement at the EU level, and organizes flagship events including EFIB, European Biotech Week, and the Patient BioForum. The association operates sector councils and platforms (Healthcare Biotechnology Council, Industrial Biotechnology Council, SME Platform, Biomanufacturing Platform) that provide members with policy influence, networking, and collective representation.

Product overview

EuropaBio is Europe’s largest biotechnology industry association, founded in 1996, representing the interests of the biotechnology ecosystem across sectors. It is not a product company but rather an industry group that engages in policy advocacy, organizes events (such as European Biotech Week, EFIB, biomanufacturing summits), facilitates member collaboration through councils (Healthcare Biotechnology Council, Industrial Biotechnology Council), operates SME and biomanufacturing platforms, and coordinates EU-funded projects (PRIMED, APROVALS). The organization does not offer commercial products or services in the traditional sense.

Differentiator

Problem solved

Functional benefit

Brands

• European Biotech Week: An annual celebration and awareness campaign for biotechnology across Europe.
• EFIB (European Forum for Industrial Biotechnology)
• Healthcare Biotechnology Council
• Industrial Biotechnology Council
• SME Platform
• Biomanufacturing Platform
• Patient BioForum

Products and services

• EuropaBio Membership (Corporate, Associate, and National Association tiers) Subscription membership in the European biotechnology industry association, available in corporate, associate, and national/regional association tiers, providing access to policy advocacy, EU-level representation, council participation, and event engagement for biotech companies and associations.
• EFIB (European Forum for Industrial Biotechnology) EuropaBio's annual conference platform convening European industrial biotechnology stakeholders, policy makers, and industry leaders, featuring statements to legislators on EU and national industrial biotechnology policy.
• European Biotech Week Annual pan-European awareness campaign and event series celebrating and promoting biotechnology, organized by EuropaBio across multiple European countries.
• Patient BioForum Annual forum convening patient organizations, healthcare biotechnology industry representatives, and the European Commission to support patient-centric policy dialogue in healthcare biotechnology.

Quantifiable outcome

• 66 out of 67 European biotech IPOs in the past six years have been listed outside Europe
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• European CRO Federation (EUCROF)coreStrategic or Co-development Partner · 26 June 2026EUCROF joined EuropaBio to advance clinical research excellence in Europe. The partnership strengthens EuropaBio's healthcare biotechnology council with expertise in contract research organization services and clinical trial coordination.
• CrystalsFirst GmbHminorStrategic or Co-development Partner · 24 June 2026CrystalsFirst, a European drug discovery services company from Hamburg, Germany integrating protein sciences, structure determination, and AI-enabled molecular design, joined EuropaBio to contribute its SME perspective on innovation and intellectual property.
• NestlécoreStrategic or Co-development Partner · 31 March 2026Nestlé joined EuropaBio to contribute to driving innovation for sustainable food systems. Nestlé brings expertise in food biotechnology and sustainable food production using biotechnology applications.
• SartoriuscoreStrategic or Co-development Partner · 4 March 2025Sartorius, a leading pharmaceutical and laboratory equipment supplier, joined to contribute to EuropaBio's biomanufacturing platform and advocacy for sustainable biotech manufacturing.
• NIBRTminorStrategic or Co-development Partner · 6 February 2025National Institute for Bioprocessing Research & Training (NIBRT) joined to contribute excellence in biopharmaceutical manufacturing processes and training to EuropaBio's ecosystem.
• Bio Base Europe Pilot PlantcoreStrategic or Co-development Partner · 3 February 2025Bio Base Europe Pilot Plant, an independent pilot and demonstration facility specializing in process development, scale-up and custom manufacturing of biobased products, joined to support EuropaBio's biomanufacturing initiatives.
• PRIMED Project ConsortiumcoreStrategic or Co-development PartnerEuropaBio joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSORTIUM, launched January 12, 2024, supported by the EU's Horizon Europe Program. Focuses on primary sector biotechnology for bioeconomy development.
• APROVALS ProjectcoreStrategic or Co-development PartnerEuropaBio joined the European APPROVALS project to support regulatory pathway navigation and sandbox sessions for biotech innovators scaling innovative technologies in Europe.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Assobiotec: Italian biotech association within Confindustria representing Italian biotech companies across red, white, and green biotech. Comparable as a national membership body and an existing EuropaBio national-association member that jointly shapes EU-level policy positions.
• France Biotech: French independent biotech association representing innovative health and industrial biotech companies. Comparable as a national membership association that funnels French biotech priorities into EU advocacy, often in coordination with EuropaBio's Healthcare and SME platforms.
• BioIndustry Association (BIA, UK): UK national biotech association and a current EuropaBio national-association member. Comparable as a membership-based biotech advocacy body engaging national and EU regulators; represents the UK life-sciences voice that EuropaBio represents upward to EU institutions.
• BIO Deutschland: German biotechnology industry association representing biotech SMEs, listed companies, and academic spinoffs. Comparable as a national biotech association that channels Germany's biotech voice into EU-level policy and coordinates with EuropaBio as a national member.

Broad incumbents

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global pharma industry association based in Geneva coordinating policy across major markets including the EU. Comparable as a multi-tier membership organization engaging WHO, WTO, and national regulators; relevant as a global-level peer that often complements EuropaBio's EU-only remit.
• BIO (Biotechnology Innovation Organization): US-based trade association representing the entire American biotechnology ecosystem across healthcare, industrial, and agricultural biotech. Direct functional analogue to EuropaBio with larger scale and US-centric policy advocacy; the natural transatlantic benchmark for European members and the most-cited comparator for policy effectiveness.
• PhRMA (Pharmaceutical Research and Manufacturers of America): Largest US pharma industry association focused on policy advocacy, IP protection, and pricing. Comparable as a membership-driven policy organization engaging government on legislation that affects biopharma R&D and commercialization; relevant benchmark for US-vs-EU policy posture for EuropaBio's healthcare council.

Emerging players

• EUCOPE (European Confederation of Pharmaceutical Entrepreneurs): European association for small-to-mid-cap pharma and biotech companies, headquartered in Brussels. Comparable as a Brussels-based biotech/pharma advocacy organization targeting EU legislation (notably the EU Biotech Act and pharma legislation), increasingly competing with EuropaBio and EFPIA for SME biotech member mindshare.

Others

• EuropaBio member cluster: Council of European BioRegions (CEBR): Network of European bio-clusters and regional biotech ecosystems. Comparable as an adjacent ecosystem-orchestration body that EuropaBio coordinates with through its National Associations Council and SME Platform to channel cluster-level policy input upward to EU institutions.

Direct peers

• EFPIA (European Federation of Pharmaceutical Industries and Associations): European pharma industry association headquartered in Brussels that, like EuropaBio, runs policy advocacy toward EU institutions on pharmaceutical legislation, market access, and IP. Most direct peer: overlapping healthcare-biotech membership base and overlapping EU policy targets, but EFPIA is pharma-heavy while EuropaBio spans healthcare plus industrial biotech and biomanufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/EuropaBio
• LinkedInlinkedin.com/company/europabio
• YouTubeyoutube.com/channel/UC5WZ2eDOcGz0jc9b6tKz4Yw
• Facebookfacebook.com/EuropaBio

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EuropaBio